P07.16 Prognostic value of contrast enhancement and histopathological grading in diffuse gliomas depends on IDH1/2 mutation

Por Suchorska, B., Biczok, A., Lenski, M., Albert, N. L., Schüller, U., Tonn, J.
Publicado no Neuro Oncol (2016)

O7.09 [(68)GA]-DOTATATE-PET IMAGING PREDICTS SOMATOSTATIN RECEPTOR II EXPRESSION IN MENINGIOMAS

Por Rachinger, W., Stöcklein, V., Haug, A.R., Schüller, U., Schichor, C., Thon, N., Tonn, J.C.
Publicado em 2014

Expression of BARHL1 in medulloblastoma is associated with prolonged survival in mice and humans

Por Pöschl, J, Lorenz, A, Hartmann, W, von Bueren, AO, Kool, M, Li, S, Peraud, A, Tonn, J-C, Herms, J, Xiang, M, Rutkowski, S, Kretzschmar, HA, Schüller, U
Publicado no Oncogene (2011)